Vygon signs exclusive agreement with Carmat for artificial heart vascular graft

Vygon has signed an exclusive agreement with Carmat to develop a new vascular graft for the Aeson artificial heart, the world's first highly hemocompatible, pulsatile and self-regulating bioprosthetic artificial heart.

“We are honored that Carmat has chosen us to develop this new vascular graft, the first of its kind in the world.”us.vygon.com

• 1 source
• us.vygon.comVygon signs an exclusive agreement with Carmat, the French manufacturer of an orthotopic artificial heart | Vygon USAJun 21, 2023

Summarized from public sources; check the original articles before acting on it.